BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 32943600)

  • 1. ABO-Incompatible Living Donor Liver Transplantation with Reduced Rituximab Dose: A Retrospective Analysis of 65 Patients - Can We Fast-Track Liver Transplant Surgery and Improve Long-Term Survival?
    Hsu SC; Thorat A; Jeng LB; Li PC; Chen TH; Yang HR; Poon KS
    Ann Transplant; 2020 Sep; 25():e923502. PubMed ID: 32943600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lessons learnt from living donor liver transplantation with ABO-incompatibility: A single-centre experience from southern India.
    Shajahan S; Sasidharan ST; Surendran S; Shenoy V; Padma UD
    Indian J Gastroenterol; 2019 Feb; 38(1):23-28. PubMed ID: 30848450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simplified protocol using rituximab and immunoglobulin for ABO-incompatible low-titre living donor liver transplantation.
    Kim SH; Lee EC; Shim JR; Park SJ
    Liver Int; 2018 May; 38(5):932-939. PubMed ID: 29053910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-Center Experience of ABO-Incompatible Living-Donor Liver Transplantation With a New Simplified Intravenous Immunoglobulin Protocol: A Propensity Score-Matching Analysis.
    Kim JD; Choi DL; Kim SG; Lee AJ
    Transplant Proc; 2016 May; 48(4):1134-8. PubMed ID: 27320573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of desensitization methods: Rituximab with/without plasmapheresis in ABO-incompatible living donor liver transplantation.
    Lee EC; Kim SH; Shim JR; Park SJ
    Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):119-125. PubMed ID: 29576278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of ABO-incompatible grafts in living donor liver transplantation--first report from India.
    Soin AS; Raut V; Mohanka R; Rastogi A; Goja S; Balachandran M; Saigal S; Saraf N; Bhangui P; Sumana KR; Singla P; Srinivasan T; Choudhary N; Tiwari A; Raina V; Govil D; Mohan N; Vohra V
    Indian J Gastroenterol; 2014 Jan; 33(1):72-6. PubMed ID: 24369388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal dosage regimen for rituximab in ABO-incompatible living donor liver transplantation.
    Egawa H; Umeshita K; Uemoto S
    J Hepatobiliary Pancreat Sci; 2017 Feb; 24(2):89-94. PubMed ID: 28002655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term Outcomes of ABO-incompatible Pediatric Living Donor Liver Transplantation.
    Honda M; Sugawara Y; Kadohisa M; Shimata K; Sakisaka M; Yoshii D; Uto K; Hayashida S; Ohya Y; Yamamoto H; Yamamoto H; Inomata Y; Hibi T
    Transplantation; 2018 Oct; 102(10):1702-1709. PubMed ID: 29620615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of rituximab in ABO-incompatible pediatric living donor liver transplantation: the experience of a single center.
    Okada N; Sanada Y; Hirata Y; Yamada N; Wakiya T; Ihara Y; Urahashi T; Miki A; Kaneda Y; Sasanuma H; Fujiwara T; Sakuma Y; Shimizu A; Hyodo M; Yasuda Y; Mizuta K
    Pediatr Transplant; 2015 May; 19(3):279-86. PubMed ID: 25689881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of ABO-incompatible adult living-donor liver transplantation for patients with hepatocellular carcinoma.
    Yoon YI; Song GW; Lee SG; Hwang S; Kim KH; Kim SH; Kang WH; Cho HD; Jwa EK; Kwon JH; Tak EY; Kirchner VA
    J Hepatol; 2018 Jun; 68(6):1153-1162. PubMed ID: 29452208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult living-donor liver transplantation with ABO-incompatible grafts.
    Testa G; Vidanovic V; Chejfec G; Gangemi A; Iqpal R; Porubsky M; Pham T; Benedetti E
    Transplantation; 2008 Mar; 85(5):681-6. PubMed ID: 18337660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experiences and problems pre-operative anti-CD20 monoclonal antibody infusion therapy with splenectomy and plasma exchange for ABO-incompatible living-donor liver transplantation.
    Usui M; Isaji S; Mizuno S; Sakurai H; Uemoto S
    Clin Transplant; 2007; 21(1):24-31. PubMed ID: 17302588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of acute kidney injury between ABO-compatible and ABO-incompatible living donor liver transplantation: A propensity matching analysis.
    Jun IG; Lee B; Kim SO; Shin WJ; Bang JY; Song JG; Song GW; Lee SG; Hwang GS
    Liver Transpl; 2016 Dec; 22(12):1656-1665. PubMed ID: 27595780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunologic strategies and outcomes in ABO-incompatible living donor liver transplantation.
    Oh J; Kim JM
    Clin Mol Hepatol; 2020 Jan; 26(1):1-6. PubMed ID: 30909688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of ABO-incompatible liver transplantation using a simplified protocol at a single institution.
    Lee J; Lee JG; Lee JJ; Kim MS; Ju MK; Choi GH; Choi JS; Kim SI; Joo DJ
    Transplant Proc; 2015 Apr; 47(3):723-6. PubMed ID: 25891718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of plasmapheresis therapy for perioperative management in ABO-incompatible adult living donor liver transplantation.
    Ashizawa T; Matsuno N; Yokoyama T; Kihara Y; Kuzuoka K; Taira S; Konno O; Jyojima Y; Akashi I; Nakamura Y; Hama K; Iwamoto H; Iwahori T; Nagao T; Kasahara M; Tanaka K
    Transplant Proc; 2006 Dec; 38(10):3629-32. PubMed ID: 17175351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of rituximab desensitization on blood-type-incompatible adult living donor liver transplantation: a Japanese multicenter study.
    Egawa H; Teramukai S; Haga H; Tanabe M; Mori A; Ikegami T; Kawagishi N; Ohdan H; Kasahara M; Umeshita K
    Am J Transplant; 2014 Jan; 14(1):102-14. PubMed ID: 24279828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABO-incompatible Living Donor Liver Transplantation With Rituximab and Total Plasma Exchange Does Not Increase Hepatocellular Carcinoma Recurrence.
    Kim JM; Kwon CHD; Joh JW; Han S; Yoo J; Kim K; Sinn DH; Choi GS; Gerber DA; Egawa H; Lee SK
    Transplantation; 2018 Oct; 102(10):1695-1701. PubMed ID: 29494419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for antibody-mediated rejection in ABO blood-type incompatible and donor-specific antibody-positive liver transplantation.
    Tajima T; Hata K; Haga H; Kusakabe J; Kageyama S; Yurugi K; Hishida R; Zhao X; Nishikori M; Nagao M; Takaori-Kondo A; Uemoto S; Hatano E
    Liver Transpl; 2023 Jul; 29(7):711-723. PubMed ID: 36749821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategic breakthrough in adult ABO-incompatible living donor liver transplantation: preliminary results of consecutive seven cases.
    Soejima Y; Muto J; Matono R; Ninomiya M; Ikeda T; Yoshizumi T; Uchiyama H; Ikegami T; Shirabe K; Maehara Y
    Clin Transplant; 2013; 27(2):227-31. PubMed ID: 23293980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.